Search This Blog

Friday, 30 November 2012

Non=Meningitis infections like epidural abscess separate from joint infections.



I see that the CDC has changed the Case Count reporting. They are now tracking the Non=Meningitis infections like epidural abscess separate from joint infections.

As of yesterday, 510 total patients with confirmed or probable infection. 360 with meningitis, and 128 with paraspinal or spinal infection alone without meningitis. There are 14 patients with peripheral joint infection and there are now 36 deaths!!! This appears to indicate an alarming progression of the paraspinal infections, although it may simply reflect the fact that more attention is now being directed toward this site of infection.

Once again, if this area had been addressed earlier in the outbreak, progressive disease might have been averted at least in a few people. Failing to address the presence of fungal colonization of the peri-epidural tissues may lead to more disease progressinon and even needless deaths.

The diagnostic tests are not precise as anyone would like, but failure to perform basic diagnostic tests, in my opinion, constitutes gross negligence!  And for any doctors who are reading this post, follow the guidance from CDC AND the ones I have posted and your patients will do as well as possible under these trying circumstances. Your patient will be satisfied that you did your best. And a satisfied patient is the least likely to mount a lawsuit.

http://www.cdc.gov/hai/outbreaks/meningitis-map.html

Wednesday, 28 November 2012

Can I work with Spinal Arachnoiditis

feed://www.socialsecuritydisability.tv/rss.xml

Can I Work With Spinal Arachnoiditis?

Spinal arachnoiditis is a disease that affects the neurological system by causing the arachnoid (a membrane surrounding the brain and spinal column) to become inflamed. This can be caused because of an adverse chemical reaction or because of bacterial or viral infections. It is also sometimes a side effect of back injuries, especially back injuries that cause the spinal column to compress.
There are several symptoms associated with spinal arachnoiditis, but different people with the condition may experience very different sets of symptoms. Some of the more common symptoms of spinal arachnoiditis include numbness and tingling in the extremities, pain in the nerves without other apparent causes (neuralgia), sexual dysfunction, and incontinence. Because it often affects the legs and lower back, it can also adversely affect a person’s ability to sit, stand, bend or walk.
Mobility in general is often a problem for those with spinal arachnoiditis because they are unable to walk without severe pain, but are also unable to effectively use mobility devices like wheelchairs because sitting for extended periods also causes a great deal of pain. This can make performing any kind of meaningful work impossible if the symptoms are severe enough.
Spinal arachnoiditis is a difficult condition to diagnose, and often isn’t diagnosed until it is fairly advanced. Some cases respond favorably to treatment, but there is no known cure for the condition.
As with any condition, your best bet for winning a Social Security Disability claim with spinal arachnoiditis is to stay under a physician’s care and make sure all physical restrictions, along with all treatment and its results, are fully documented. You may consider contracting a Social Security Disability lawyer to make sure that your claim is in order. Claimants who are represented are much more likely to have their Social Security Disability claims approved.

Spinal Arachnoiditis and Your Ability to Perform Physical Work

If you have severe symptoms of spinal arachnoiditis, you will have little trouble proving that you are incapable of performing physical labor. If your symptoms are less severe, you will need to show that they are serious enough to prevent you from performing meaningful work.
Anything which hinders your ability to stand, walk, lift, bend, push or pull will be considered by the SSA when determining whether you are capable of performing any physical work. To qualify for Social Security Disability benefits, you must show that you are incapable of performing any work which you have ever done previously, especially during the past 15 years. You will also need to show that you are incapable of other physical work that is available and which you are qualified for.
All restrictions should be stated in your medical records in terms of what you can and cannot do, including the amount of time you can stand, the amount of weight you can lift, and any other specific limitations to your daily activities which your spinal arachnoiditis causes.

Spinal Arachnoiditis and Your Ability to Perform Sedentary Work

If your spinal arachnoiditis causes you to have difficulty sitting for extended periods of time (and it usually will), you will be able to establish that you are incapable of performing sedentary work. By the SSA’s definition, you are incapable of performing sedentary work if you are unable to sit in one place for six hours at a time. You should also make sure to include any limitations to your fine motor skills that are caused by spinal arachnoiditis, as these will also be considered when determining whether or not you qualify for Social Security Disability benefits.
Many Social Security Disability claims are denied. Over two thirds of claimants are faced with the daunting proposition of going through a lengthy appeals process. If you find yourself in this position, contact a Social Security Disability lawyer. Having qualified representation makes the Social Security Disability less stressful and offers you your best chance of having your claim ultimately approved.

N.O.R.D FINANCIAL AND MEDICATION ASSISTANCE RESOURCES

http://www.rarediseases.org/rare-disease-information/resources-tools/financial-med-assistance#free-or-reduced-cost-medical-care


Home › Rare Disease Information › Other Resources and Tools › Financial and Medication Assistance Resources

FINANCIAL AND MEDICATION ASSISTANCE RESOURCES

Go directly to a section of this page:


MEDICATION ASSISTANCE RESOURCES

*If you can not find a patient assistance program for your medication, try contacting the manufacturer of the drug for possible program opportunities or financial assistance.
NORD’s Patient Assistance Programs help patients obtain life-saving or life-sustaining medication they could not otherwise afford.
NeedyMeds is a 501(c)(3) nonprofit with the mission of helping people who cannot afford medicine or health care costs. The information at NeedyMeds is available anonymously and free of charge.
RxAssist offers a comprehensive database of patient assistance programs, as well as practical tools, news, and articles so that health care professionals and patients can find the information they need. Patient assistance programs are run by pharmaceutical companies to provide free medications to people who cannot afford to buy their medicine.
The Abigail Alliance is committed to helping create wider access to developmental cancer drugs and other drugs for serious life-threatening illnesses. The Alliance is promoting creative ways of increasing expanded access and compassionate use programs and working to help promote creative ideas to get promising new drugs to the market sooner.
Care Connect USA has assembled a free list of family relief hotlines for financial assistance in critical categories. Some of these hotlines are government agencies, and some are privately administered. All have met there standards of practice, and are monitored for continued effectiveness.
Edmund Hayes provides a Newsletter, Blog and Web Page designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. The list contains the name and telephone numbers of companies that have indigent programs in place.
Healing the Children works to heal children with burn injuries, cleft palates and other deformities whose families don't have access to or cannot afford treatment.
The HealthWell Foundation is a 501(c)(3) non-profit organization established in 2003 that is committed to addressing the needs of individuals with insurance who cannot afford their copayments, coinsurance, and premiums for important medical treatments.
Hill-Burton Free and Reduced Cost Health Care provides a reasonable volume of services to persons unable to pay for hospitals, nursing homes and other health facilities, and to make their services available to all persons residing in the facility’s area.
The National Alliance on Mental Illness (NAMI) compiled a list of free or low-cost mental health medications provided by pharmaceutical companies.
The National Human Genome Research Institute provides some resources for finding information on financial aid for medical treatment, although it is not authorized to provide routine medical assistance or treatment funds.
The Patient Advocate Foundation (PAF) Co-Pay Relief Program (CPR) currently provides direct financial support to insured patients, including Medicare Part D beneficiaries, who must financially and medically qualify to access pharmaceutical co-payment assistance.
The Patient Access Network (PAN) Foundation was founded in October 2004 as a solution to help the underinsured access the health care they so desperately need to continue living a relatively normal and productive lifestyle.
Patient Services, Inc. (PSI) provides peace of mind to patients living with specific chronic illnesses by: locating health insurance in all 50 states, subsidizing the cost of health insurance premiums, providing pharmacy and treatment co-payment assistance, assisting with Medicare Part D Co-insurance, and helping with advocacy for Social Security Disability.

EDUCATION RESOURCES

The College Board is a not-for-profit membership association whose mission is to connect students to college success and opportunity. The College Board is committed to the principles of excellence and equity, and that commitment is embodied in all of its programs, services, activities and concerns.
Educational Equity Center at AED develops programs and materials that promote bias-free learning in school and after school. We provide professional development, consulting services, and community partnerships.
Federal Student Aid, an office of the U.S. Department of Education, plays a central and essential role in America's postsecondary education community. Our core mission is to ensure that all eligible individuals benefit from federal financial assistance—grants, loans and work-study programs—for education beyond high school.
FinAid was established in the fall of 1994 as a public service. This site has grown into the most comprehensive source of student financial aid information, advice and tools -- on or off the web.
Learning Disabilities Association of America creates opportunities for success for all individuals affected by learning disabilities and to reduce the incidence of learning disabilities in future generations.
The National Center for Learning Disabilities (NCLD) works to ensure that the nation's 15 million children, adolescents, and adults with learning disabilities have every opportunity to succeed in school, work, and life.

FREE OR REDUCED COST MEDICAL CARE

The National Association of Free Clinics (NAFC) is the only nonprofit 501c(3) organization whose mission is solely focused on the issues and needs of the more than 1,200 free clinics and the people they serve in the United States.
Shriners Hospitals for Children® is a health care system of 22 hospitals dedicated to improving the lives of children by providing pediatric specialty care, innovative research, and outstanding teaching programs for medical professionals. Children up to age 18 with orthopaedic conditions, burns, spinal cord injuries, and cleft lip and palate are eligible for care and receive all services in a family-centered environment, regardless of the patients’ ability to pay.
St. Jude Children’s Research Hospital’s mission is to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment. No child is denied treatment based on race, religion or a family's ability to pay.
Texas Scottish Rite Hospital for Children is a world leader in the treatment of pediatric orthopedic conditions. We strive to improve the care of children worldwide through innovative research and teaching programs, training physicians from around the world.

CANCER FINANCIAL SUPPORT

The Cancer Financial Assistance Coalition helps cancer patients experience better health and well-being by limiting financial challenges, through: facilitating communication and collaboration among member organizations; educating patients and providers about existing resources and linking to other organizations that can disseminate information about the collective resources of the member organizations; advocating on behalf of cancer patients who continue to bear financial burdens associated with the costs of cancer treatment and care.
Cancer Care is an organization that provides professional support services to anyone affected by cancer. CancerCare programs—including counseling and support groups, education, financial assistance and practical help—are provided by professional oncology social workers and are completely free of charge.
Lance Armstrong Foundation works to identify the issues faced by cancer survivors in order to comprehensively improve quality of life for members of the global cancer community.
The Leukemia & Lymphoma Society Co-Pay Assistance Program helps you pay your insurance premiums and meet co-pay obligations. We'll also help you find additional sources of financial help.
The National Cancer Institute is part of the National Institutes of Health, and supports and coordinates research projects conducted by universities, hospitals, research foundations, and businesses throughout this country and abroad through research grants and cooperative agreements. They also collect and disseminate information on cancer.
The American Cancer Society’s Road to Recovery Program provides free transportation for cancer patients. Cancer patients receiving treatment at a nearby hospital or medical facility can get free transportation to and from their treatment site. The American Cancer Society’s Road to Recovery program is a free service for cancer patients who lack transportation.
Cancer Legal Resource Center is a national, joint program of the Disability Rights Legal Center and Loyola Law School Los Angeles. The CLRC provides free information and resources on cancer-related legal issues to cancer survivors, caregivers, health care professionals, employers, and others coping with cancer.

TRAVEL ASSISTANCE AND RECREATION RESOURCES

The National Patient Travel HELPLINE provides information about all forms of charitable, long-distance medical air transportation and provides referrals to all appropriate sources of help available in the national charitable medical air transportation network.
Patient AirLift Services arranges free air transportation based on need to individuals requiring medical care and for other humanitarian purposes.
TSA Cares is a helpline to assist travelers with disabilities and medical conditions. TSA recommends that passengers call 72 hours ahead of travel to for information about what to expect during screening.
Double "H" Hole in the Woods Ranch provides specialized programs and year-round support for children and their families dealing with life-threatening illnesses.
New Directions for people with disabilities, inc. is a 501(c)(3) non-profit organization providing high quality local, national, and international travel vacations and holiday programs for people with mild to moderate developmental disabilities.
The Association of Hole in the Wall Camps is an international family of camps and programs that provide life-changing experiences to children with serious medical conditions, always free of charge.  Their goal is to extend these experiences to as many children as possible around the world.
Hospitality Homes provides temporary housing in volunteer host homes and other donated accommodations for families and friends of patients seeking care at Boston-area medical centers.
The National Association of Hospital Hospitality Houses supports homes that help and heal to be more effective in their service to patients and families.

Changing Clinical Picture of Meningitis Outbreak, Arachnoiditis

http://www.medscape.com/viewarticle/775140?src=nldne&uac=179920ST



Changing Clinical Picture of Meningitis Outbreak

Megan Brooks
  Nov 27, 2012 Authors & Disclosures
 
More than 2 months after the 3 lots of injectable methylprednisolone acetate (MPA) produced by the New England Compounding Center (NECC) were implicated in the fungal meningitis outbreak and recalled, the Centers for Disease Control and Prevention (CDC) continues to receive reports of fungal meningitis and other infections in exposed patients, the CDC said today.
"As of November 26, a total of 510 cases, including 36 deaths, have been reported in 19 states," reported Melissa K. Schaefer, MD, medical officer, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC, during a Clinician Outreach and Communication Activity (COCA) call, the fourth COCA call since the outbreak began.
Exserohilum rostratum continues to be the predominant fungus identified in patients and confirmed by the CDC laboratory. Previously, the majority of cases reported to CDC were of patients with fungal meningitis after injection with contaminated MPA, noted John Jernigan, MD, who is also a medical officer in the Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases at CDC.
And although cases of fungal meningitis continue to be reported, CDC is "seeing a transition in the clinical presentation of the cases that are being reported," he said.
"We have recently observed an increase in the number of patients presenting with evidence of epidural abscess, phlegmon, discitis, vertebral osteomyelitis, or arachnoiditis at or near the site of injection and we see these complications occurring in patients both with and without evidence of fungal meningitis," Dr. Jernigan said.
A Transition in Clinical Presentation
According to CDC, of the 91 cases reported to CDC since November 4, 26 (29%) were classified as meningitis, 61 (67%) had spinal or paraspinal epidural abscess or osteomyelitis, 2 (2%) had peripheral joint infection, and 2 (2%) had more than 1 condition.
"It's important to note that the overall trend in the number of cases being reported is still going down; it's just that a larger proportion of those that are being recently reported are some of these paraspinal or spinal infections," Dr. Jernigan said.
Patients with these localized infections frequently have new or worsening back pain. Yet, it's "important to note that the symptoms may in fact be quite mild or very clinically difficult to distinguish from the patient's baseline chronic pain that called for the injection in the first place," Dr. Jernigan said.
He said the CDC's current diagnostic and treatment guidance addresses management of patients with epidural abscess or other complications at or near the injection site.
On the basis of current information, the CDC recommends the following diagnostic protocol:
  • In patients with new or worsening symptoms at or near the injection site, physicians should obtain an MRI with contrast of the symptomatic areas, if not contraindicated. This recommendation also applies to patients being treated for meningitis. In some cases, radiologic evidence of abscess or phlegmon has become apparent on repeat MRI studies performed after an initially normal imaging procedure. Clinicians should therefore have a low threshold for repeat MRI studies in patients who continue to have symptoms localizing to the site of injection, even after a normal study result. However, the optimal duration between MRI studies is unknown.
  • CDC has received reports of patients being treated for fungal meningitis who had no previous evidence of localized infection at the site of injection but who were subsequently found to have evidence of localized infection (eg, epidural abscess, phlegmon, discitis, vertebral osteomyelitis, or arachnoiditis) on imaging studies. Therefore, in patients being treated for meningitis, even in the absence of new or worsening symptoms at or near the injection site, clinicians should strongly consider obtaining an MRI of the injection site approximately 2 to 3 weeks after diagnosis of meningitis. Early identification of new disease may facilitate additional specific interventions (eg, drainage) and provide information for measuring effectiveness of therapy thereafter.
  • For patients demonstrated to have epidural abscess, phlegmon, discitis, vertebral osteomyelitis, or arachnoiditis, early consultation with a neurosurgeon to discuss whether surgical management, including debridement, is warranted in addition to antifungal therapy. For information about antifungal therapy, see Interim Treatment Guidance for Central System and Parameningeal Infections Associated with Injection of Contaminated Steroid Products.
Clinician Consultation Network
The CDC has set up a Clinician Consultation Network to assist clinicians managing patients with fungal meningitis and other infections associated with contaminated MPA injection.
This is a "network of infectious disease experts who have special expertise in treating fungal infections who are being made available through the CDC to clinicians who are caring for patients involved in this outbreak if they need additional assistance or additional information on individual patient management," Dr. Jernigan said.
To access the Clinician Consultation Network and be put in touch with an expert, clinicians can call 1-800-CDC-INFO.
 

Monday, 26 November 2012

Microsurgical fenestration of perineural (tarlov cysts)

Microsurgical fenestration of perineural cysts to the thecal sac at the level of the distal dural sleeve.



Sacral perineural cysts (Tarlov cysts) are cysts of the sacral nerve roots. They rarely become symptomatic, but have been associated with lumbar and sacral pain, pseudoradicular and radicular symptoms, and bowel and bladder dysfunction []. Perineural cysts, most of which were asymptomatic, showed a prevalence of 1.5% to 4.6% in radiological studies []. Their etiology remains unclear (reviewed in []). Micro-communications at the distal dural sleeve of the nerve root functioning as a valve that allows CSF influx while restricting CSF efflux is thought to be one possible underlying pathomechanism of perineural cyst growth []. Cyst expansion may eventually lead to irritation or compression of the affected or adjacent nerve roots, and erosion of surrounding bone with consecutive irritation of periostal pain fibers.
Cystic lesions of the sacral region can be diagnosed by CT or MRI. The presence of a communication between the cyst and thecal sac differentiates perineural cysts from other cystic lesions []. These micro-communications can be demonstrated by myelography and postmyelographic CT. Delayed contrast filling of the cystic lesion indicates the presence of micro-communications and hence a possible valve mechanism [].
More from the link above, Portugal

Friday, 16 November 2012

Every chronic Patient should read this it explains Dependence Addiction, Tolerancec

Addiction, Tolerance, and Dependence—An Interview with Dr www.jenniferschneider.comFollowing is managing editor Jennifer Lobb’s interview with Jennifer Schneider, MD, PhD, a pain management specialist and addiction medicine specialist. Dr. Schneider is the author of Living with Chronic Pain and numerous other books and wrote Addiction and Chronic Pain for NPF last month.


Addiction, Tolerance, and Dependence—An Interview with Dr. Jennifer Schneider

(Posted on the website of the National Pain Foundation, April, 2005)

Following is managing editor Jennifer Lobb’s interview with Jennifer Schneider, MD, PhD, a pain management specialist and addiction medicine specialist. Dr. Schneider is the author of Living with Chronic Pain and numerous other books and wrote Addiction and Chronic Pain for NPF last month.


JL:  Tell me a little bit about how you became a pain specialist.

Dr. Schneider:  Well, I started out as an internist in 1980 and became interested in addiction medicine about 10 years later because of family addiction problems.  I then got additional training and certification by the American Society of  Addiction Medicine.  I was doing internal and addiction medicine and was sharing an office with a physician who specialized in pain medicine. He was one of these pioneers who was using opioids to treat chronic non-malignant pain in the early 1990s.  He decided to move and asked if he could transfer his patients to me.  Of course, I was freaked out like most doctors are, but he said “They’re good patients, it’s easy. All you have to do is just read the chart and keep doing what I’ve been  doing.”  I ended up learning from the patients, really, because these happened to be very responsible, reliable patients, so it was an education for me.  I think that’s really the most effective way to convince doctors who are scared of prescribing — to actually see people who are benefiting from the treatment.  And that’s what happened to me.  I started getting referrals from other doctors to evaluate their pain patients who they feared were  “drug seekers” who were really undertreated pain patients.  I started getting requests to be an expert witness, so I decided that I better get some extra credentials and I became certified by the American Academy of Pain Management a couple of years ago.


JL:  Let’s talk about how opioids work physiologically, in lay terms if possible.


Dr. Schneider:  OK, There are receptors in the periphery and in the central nervous system that opiates bind to — mu receptors are the most important ones, but there are also delta and kappa receptors.  When these receptors are occupied by opioids, they release some neuro chemicals that alleviate pain.


JL:  What is the difference between physical dependence, tolerance, and addiction?


Dr. Schneider:  There’s a huge difference.  Physical dependence is a property of many different classes of drugs, not just drugs that can be abused.  Physical dependence is a property of steroids, for example.  What it means is that if a person stops that drug suddenly, there is a predictable physiologic response by the body. 

For example, when you are physically dependent on exogenous steroids, meaning steroids that are outside the body in medication form like prednisone, your brain stops putting out chemicals that cause your body to release endogenous steroids, the steroids produced within your body.  The pituitary gland normally puts out a hormone that stimulates the adrenal gland to produce epinephrine, which is adrenalin.  When you’re on the steroid medication, the body stops producing it.  What happens is, if you stop taking prednisone suddenly, your body is left without the endogenous steroids, the steroids your body usually produces.  Clearly, the person has become physically dependent on the prescribed steroids and the solution to it, if they don’t need the medication any more is to taper it  slowly so that the body gets a chance to reverse those changes.  Opioids also can, and usually do, cause physical dependence.  The body makes changes to adapt to the opioids and if you stop suddenly, you get this unpleasant withdrawal syndrome. 

That’s what physical dependence is — it has nothing to do with addiction.  Addiction is not necessarily a physical thing.  Addiction is a psychological phenomenon consisting of three elements.  One is loss of control, which means you intend to use only so much but when you have access you keep taking the substance.  The second is continuation despite significant adverse consequences, which means even if the substance – let’s say alcohol -- is causing liver damage, you’re arrested for a DUI, or are fired from your job, you still take it.  In fact, one of the major differences between chronic pain patients and addicts is that the opioids expand the life of the pain patient.  They make things better — they improve the patient’s functioning and pain whereas with the addict, their life constricts and they become more and more focused on the drug that they are misusing.  So you have the opposite effect, and that’s what I’m talking about when I say addicts continue to use it despite adverse consequences.   Pain patients  on prescribed opioids don’t have adverse consequences — they may have side effects from opioids but they don’t have these types of adverse consequences (eg, loss of a job, organ damage).  The third element of addiction is the preoccupation or obsession with obtaining, using, and recovering from the effects of the drug.

Tolerance is the need for more to get the same effect.  Tolerance is a big issue in prescribing opioids.  Everyone knows that drug addicts have to keep increasing their dose to get a high.  What most people don’t know is that tolerance to the different effects of opioids differs  What I’m saying is there are generally four effects of opioids on the body.  Three of them we call side effects and these are sedation, nausea and constipation.  The fourth effect is the desired one -- pain relief.  So opioids have four effects.  It turns out that tolerance, meaning that you get less effect as you continue the same dose or that you need more medication to get the same effect, tolerance develops to two out of those four effects — sedation and nausea.  Doctors realize you don’t develop much tolerance to constipation and that patients taking opioids have to be on a bowel program.  But, what most doctors and patients do not realize is that you don’t develop much tolerance to the pain-relieving effects of opioids.  What happens — when it comes to pain relief — is that most patients, once they’ve reached an effective dose, stay on the same dose for a long time.  Sometimes they need a little upward increase but it’s not a significant thing.  The usual reasons that a chronic pain patient needs a dose increase is either that they’re doing more physical activities, or that their disease has progressed.

So why is it that heroin addicts need more and more?  The reason is because tolerance develops very, very quickly to the euphoria-producing effects of the drug.  What causes a buzz from a drug is not the concentration in the blood stream.  For example, you can have pain patients who have a little bit of the drug in their body and other pain patients who have a very high level in their blood in order to get pain relief, but neither of these people are likely to experience a buzz.  What causes a buzz is the rate of increase — rate of change — in the brain.  People develop a tolerance very rapidly to this.  So anytime somebody says, “Isn’t true that people become tolerant to opioids?” the answer has got to be, “What do you mean by tolerance? What specific effect of the opioids are you asking about?”  That’s a really important point.  You don’t just develop tolerance or not develop tolerance.  It’s a widespread misunderstanding.


JL:  Why is there such a stigma surrounding opioids?


Dr. Schneider:  The Diagnostic and Statistical Manual of Mental Disorders provides definitions of various psychiatric disorders, including drug dependency. The thing that’s really confusing is that previous editions of this book talked about addiction, like drug addiction.  But the psychiatrists, in their wisdom, decided that addiction was a bad word and they took it out of the book and substituted the word dependency. 


JL:  So it creates confusion with physical dependence. . .

Dr. Schneider:  Exactly.  So now, when you open the DSM-IV and you read about dependency, they’re talking about addiction — they are not talking about physical dependency.  It’s created a huge confusion that is so immense that most doctors misunderstand this.

Part of the stigma is related to this incredible confusion.  When I’m giving a talk to doctors, I start out with a true-false quiz, you know, to get their attention because most people sleep through talks [laughs].  Anyway, the first question I ask is, “True or false:  Most patients who are on opioids for more than a short period of time and more than minimum doses become addicted.”  I’d say 95% of the audience usually says that’s true. And of course, the right answer is that it’s false.


JL:  That’s frightening.

Dr. Schneider:  Well, it is frightening.  And it shows you the huge confusion in the medical community.  Obviously, patients are just as confused, as are journalists who are writing these scary articles in the newspapers about opioids and how you can become addicted. 

Let me just put my two cents in about famous people who blame their doctors, you know the ones who say, “My doctor made me addicted because I saw him for pain and he gave me these medications.”  In some of these cases, these people had been treated for chemical dependency in the past.  These are not people who don’t have risk factors and some of them undoubtedly should never have been put on some of these medications in the first place because of their history.  What I’m saying is, most of these famous people who say their doctors got them addicted are not exactly telling you  what really went on but it certainly makes an impression on the public in thinking how easy it is to get addicted.


JL:  What are some of the psychological factors that may cause a person to abuse medications? What makes someone more at risk for developing addiction?

Dr. Schneider:  The biggest one is a history of addiction.  If they themselves have had a drug addiction in their past and if they’ve been through treatment or are in recovery from drug addiction, they’re definitely more at risk psychologically and they’re probably more at risk physically because sometimes addiction causes brain changes that are fairly permanent.

A family history is a risk factor for two reasons. First of all, there are genetic predispositions to addiction that are very well established with alcohol addiction, less so with some of the others, but most addiction specialists think that there’s a tendency for vulnerability to all drug addictions to be genetic.  The second thing is that growing up in a dysfunctional family creates some psychological vulnerabilities.  In other words, if you grow up in an alcoholic family, you not only have the genetic predisposition, but you also have grown up in chaos and dysfunction.  The thing about an addict is that the addiction is the number one thing in his or her life — more important than being a parent, so kids in this situation aren’t going to have the nurturing and attention they need.

People who’ve had psychological trauma in their lives are more vulnerable to addiction.  I’ll give you an example of that related to Vietnam.  The government thought it would be treating huge numbers of veterans coming back from Vietnam for drug addiction because so many of them used drugs while they were there.  What they found out was that only a small proportion of them continued to use drugs when they got back to the US and were addicted.  The others, when they got back to their regular lives, they stopped.  Their use was situational — they were there in Vietnam, the situation was terrible, the drugs provided a great escape, but when they got back to the real world, they stopped.  The question is, why did some continue to use and others didn’t?  It turns out that the ones who continued to use were the ones who had vulnerabilities to begin with — people who had dysfunctional families, chaos in their lives, genetic predispositions.

When you’re talking about treating people with prescription medications, you’re going to have people who have this predisposition and have those who don’t — most of them don’t. 

There’s also a matter of the support system people have.  There was a small study done by Dunbar and Katz of 20 patients with a personal history of  drug or alcohol addiction who were treated with opioids for some chronic non-cancer pain problem.  They found that 12 did well and eight got back into addiction.  When they looked at the reasons,  the authors  found out that the people who got back into uncontrolled use of the drug where those who, first of all, in the past were addicted to narcotics and not to alcohol, or else to multiple drugs; second, they were not involved in addiction recovery activities, like Alcoholics Anonymous; and third, they tended to have less family support and a less stable lifestyle.  If you’re talking about someone who’s seriously involved in Alcoholics Anonymous, who has a job and a family, that person has a lot lower risk.


JL:  Can a person who has had an addiction be treated with opioids?


Dr. Schneider:  Yes, definitely. But it depends. It depends on exactly these things I just talked about.  I’ve treated people with opioids for pain who have had an addiction history, but the first thing I do is ask about their history — how long ago was the addiction?  If it was 30 years ago rather than one year ago, well, that’s going to make a big difference.  What, in terms of recovery activities, are they involved with?  Their lifestyle — are these people who have family support or are they living alone?  The other thing is, when I treat anyone with an addiction background, I first of all make sure I’m aware of the addiction and if I do decide to treat him or her, I make sure that they have structure around them. 

In other words, if they’re involved in recovery work, they need to have a sponsor and they need to make sure that their sponsor is aware that they are being treated with opioids for chronic pain and that their sponsor is supportive of the treatment.  They need to talk about it.  I tend to be less willing to give them breakthrough pain medications because the short-acting opioids cause more euphoria because they get into the brain faster.  Anybody I have the slightest concern about, I’m not going to put him or her on a drug for breakthrough pain.  In fact, I am more likely to use a drug like Duragesic, which is a two- or three-day fentanyl patch, so they don’t have to think about taking pills often.  In other words, you don’t want them to be thinking about their next dose all day.  My goal in treating all chronic pain patients is to have them think about their chronic pain meds the same way they think about their blood pressure medications.  We just take them in the morning and evening and then we don’t think about it anymore.  I want them to just be treating yet another medical problem with some medication that they take and not think about it.   

I also do more urine drug screens on people with an addiction background.  I don’t test everyone -- it’s on a case-by-case basis, but I build more structure around them.  For example, I had a guy who came in for back pain and when I did the urine drug screen, it came back positive for cocaine.  I told him that if I was going to treat him, he was going to have to get his cocaine addiction treated.  And he did — he started going to a recovery group and I kept getting urine drug screens on him to make sure there wasn’t any cocaine and to show him that I was serious.  You have to build motivation for people to change.  Change is hard for anybody — I mean, look at losing weight – most overweight people can give a lecture on how to lose weight, but it’s hard to actually follow their own advice.   I told him, “If cocaine shows up in your urine again, I’m not going to prescribe for you.”  So, in that way, I gave him incentive to get involved.  He eventually became self-motivated. 

It’s very tricky though.  If someone has an addiction background around and looks like they are at risk, I wouldn’t recommend that anyone who doesn’t have both an addiction background and a pain background treat them with opioids for pain.

JL:  What credentials or experience should a patient who had a previous addiction look for in a physician? How do they find a physician like you who has the background in both?

Dr. Schneider:  Well, it’s difficult.  They need to find someone who’s a pain management doctor who’s going to be sympathetic to pain issues who is also knowledgeable about addiction.  They’re not that common. 


JL:  Is there an organization they can look into?

 

Dr. Schneider:  There’s the American Society of Addiction Medicine, with more than 3,000 addiction medicine doctors.  You can look them up on the Internet at www.asam.org.  The problem is some of them are very much against using opioids for chronic pain, but there is a minority in the organization that truly understands.  ASAM has a special pain and chemical dependency committee, of which I’m a part, of doctors who are very knowledgeable in both areas.  It is possible to find someone — start out with a pain specialist.  Sometimes the pain specialist can refer the patient to an addiction specialist to get an opinion on his or her situation.  That’s another way to go.



JL:  What can patients do to help their families understand how and why these opioids may be appropriate for them?

Dr. Schneider:  This is a big problem for pain patients.  Sometimes I have patients coming to see me specifically to get off the opioids.  Naturally, these are exactly the people who have never abused drugs, they’re the opposite of people who I agree should be off opioids. My first question when somebody comes in and their specific agenda is getting off the morphine that they take for chronic pain is, “Why? Why do you want to get off it?”  And along with that, I ask, “Is the medicine helping you?  If the medicine is helping, why do you want to get off of it?” 

Do you know what most of them tell me? Not because it’s giving them side effects.  Why do you think they want to get off of it?

JL:  Because their family wants them to?

Dr. Schneider:  Exactly.  There are getting heat from their friends and family — they hear things like “You’re an addict,” and “If you’re not, you will be,” and “This is terrible.”  The patients feel stigmatized.  That’s the main reason they want to stop taking opioids. 

 

When I find out that it’s their family, I ask them “What’s your plan for dealing with your pain after you stop taking these medications?” and, you know, they never have a plan.  They just don’t want to take the heat from their family anymore.  What I usually do is explain to them about the difference between addiction and physical dependence, which of course their families don’t understand and the patients don’t either, I give them an article on my web site (www.jenniferschneider.com) that I wrote for a case management journal that explains a lot of this and is fairly easy to understand, and I suggest that they bring their family member in with them because the family member is never going to listen to the patient.  What’s going to happen is that the patient will go home and say, “The doctor said I should stay on because . . . .” and the family member isn’t going to buy it.  They’ll think the patient is just hearing what they want to hear, so it’s better if the family member hears it directly  from me. This is a big issue.  If a spouse  is very opposed to having his wife or her husband being treated with opioids, I will not prescribe unless the spouse comes in and we can get the situation worked out.